During the initial phases of the HIV epidemic, epidemiological and preventi
on initiatives included a necessary focus on injection drug use which targe
ted, for the most part, heroin injectors. More recently, cocaine users have
become a central focus for many HIV prevention interventions. This illustr
ates how researchers and public health practitioners have adapted to the ch
anging and intersecting epidemics of HIV and drug abuse in order to more ef
ficiently prevent the spread of HIV among drug abusers. In this special iss
ue of Drug and Alcohol Dependence, the contributing authors focus attention
on the HIV risk behaviors of cocaine abusers using data from the National
Institute on Drug Abuse (NIDA) Cooperative Agreement for AIDS Community;Bas
ed Outreach/Intervention Research Program. The Cooperative Agreement consis
ts of 23 sites, with 22 sites located in the US (including Puerto Rico) and
one site in Brazil, and has included over 28 000 subjects recruited using
street outreach. All Cooperative Agreement subjects were administered the:N
IDA risk behavior assessment (RBA) which provides detailed information abou
t injection drug use behaviors, crack cocaine use and sexual behaviors. The
RBA serves as the source of basic data for all papers in this issue which
includes work describing local studies in St. Louis, North Carolina and Bra
zil as well as analysis of the National Database from researchers in Denver
, Washington and Kentucky. In general, the studies focus on the etiology of
HIV risk behaviors by empirically identifying the antecedents of individua
l HIV risk behaviors among cocaine users. These predictors of risk and prot
ective behavior include the severity of crack cocaine, comorbid antisocial
personality disorder and depression, alcohol consumption, and typologies of
crack and injection drug use. Overall, the studies show that NIDA's preven
tion intervention is feasible and effective in many settings. The success o
f the studies which are included in this special issue is a testament to th
e feasibility of NIDA's science-based prevention interventions. (C) 2000 El
sevier Science Ireland Ltd. All rights reserved.